Related Experiment Videos

Adrenal hemorrhage in infants undergoing ECMO: prevalence and clinical significance

C M Sivit1, B L Short, M E Revenis

  • 1Department of Diagnostic Imaging and Radiology, Children's National Medical Center, Washington, DC 20010.

Pediatric Radiology
|January 1, 1993
PubMed

Insights

Adrenal hemorrhage is uncommon in infants receiving extracorporeal membrane oxygenation (ECMO) therapy. In this study, diagnosed adrenal hemorrhages did not lead to clinical complications in infants on ECMO.

Area of Science:

  • Pediatric Critical Care
  • Neonatology
  • Medical Imaging

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for neonates with severe cardiorespiratory failure.
  • Adrenal complications, including hemorrhage, can occur in critically ill infants.
  • Understanding the incidence and impact of adrenal hemorrhage during ECMO is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of adrenal hemorrhage in infants undergoing ECMO.
  • To assess the clinical significance and potential complications of adrenal hemorrhage in this population.

Main Methods:

  • Prospective ultrasonography (US) of the adrenal glands in 50 consecutive infants on ECMO.
  • Regular US examinations (at least every other day) during ECMO support.
  • Diagnosis of adrenal hemorrhage based on US findings of suprarenal mass or adrenal gland enlargement.

Main Results:

  • Adrenal hemorrhage was identified in 4% of infants (2 out of 50).
  • Hemorrhages were unilateral and occurred within the first three days of ECMO.
  • No association was found between adrenal hemorrhage and acute hematocrit drop or adrenal insufficiency.

Conclusions:

  • Adrenal hemorrhage is an infrequent complication in infants undergoing ECMO.
  • In this series, identified adrenal hemorrhages did not result in discernible clinical complications.
  • Further research may be warranted to fully elucidate long-term outcomes.
Abstract

Related Concept Videos